{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:30:51Z","timestamp":1791477051967,"version":"4.3.4"},"reference-count":38,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,12,30]]},"published-print":{"date-parts":[[2026,4]]},"DOI":"10.2967\/jnumed.125.270083","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:25:27Z","timestamp":1770315927000},"page":"576-583","source":"Crossref","is-referenced-by-count":1,"title":["A Phase 0 Imaging Trial of [\n                    <sup>203<\/sup>\n                    Pb]Pb-VMT-a-NET to Enable Dosimetry and Treatment Planning for Refractory or Relapsed Metastatic Neuroendocrine Tumors with [\n                    <sup>212<\/sup>\n                    Pb]Pb-VMT-a-NET"],"prefix":"10.2967","volume":"67","author":[{"given":"Stephen A.","family":"Graves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Bushnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchay","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie L.","family":"Bodeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Menda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"2026040105551070000_67.4.576.1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","article-title":"Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?","volume":"23","author":"Das","year":"2021","journal-title":"Curr Oncol Rep."},{"key":"2026040105551070000_67.4.576.2","first-page":"472","volume-title":"Sleisenger and Fordtrans Gastrointestinal and Liver Disease: Pathophysiology\/Diagnosis\/Management.","volume":"1","year":"1998"},{"key":"2026040105551070000_67.4.576.3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1053\/ejso.2001.1132","article-title":"131I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome","volume":"27","author":"Pathirana","year":"2001","journal-title":"Eur J Surgl Oncol."},{"key":"2026040105551070000_67.4.576.4","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2009.0672"},{"key":"2026040105551070000_67.4.576.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.217463"},{"key":"2026040105551070000_67.4.576.6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20592"},{"key":"2026040105551070000_67.4.576.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2026040105551070000_67.4.576.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00572-6"},{"key":"2026040105551070000_67.4.576.9","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2006.01.001"},{"key":"2026040105551070000_67.4.576.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-1833-x"},{"key":"2026040105551070000_67.4.576.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.191395"},{"key":"2026040105551070000_67.4.576.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2857-9"},{"key":"2026040105551070000_67.4.576.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264043"},{"key":"2026040105551070000_67.4.576.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263230"},{"key":"2026040105551070000_67.4.576.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05474-1"},{"key":"2026040105551070000_67.4.576.16","unstructured":"Sgouros G Ulaner G Delie T . 225Ac-DOTATATE dosimetry results from part 1 of the ACTION-1 Trial. Soc Nuclear Med. 2023."},{"key":"2026040105551070000_67.4.576.17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/RLU.0000000000002915","article-title":"Peptide receptor radionuclide therapy using 225Ac-DOTATOC achieves partial remission in a patient with progressive neuroendocrine liver metastases after repeated -emitter peptide receptor radionuclide therapy","volume":"45","author":"Zhang","year":"2020","journal-title":"Clin Nucl Med."},{"key":"2026040105551070000_67.4.576.18","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00259-023-06494-9","article-title":"Structural modifications toward improved lead-203\/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors","volume":"51","author":"Lee","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551070000_67.4.576.19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.apradiso.2017.05.006","article-title":"Automated cassette-based production of high specific activity [203\/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer","volume":"127","author":"Li","year":"2017","journal-title":"Appl Radiat Isot."},{"key":"2026040105551070000_67.4.576.20","first-page":"1433","article-title":"Evaluation of a scalable qSPECT calibration method for radiopharmaceutical dosimetry [abstract]","volume":"62(suppl 1)","author":"Graves","year":"2021","journal-title":"J Nucl Med."},{"key":"2026040105551070000_67.4.576.21","doi-asserted-by":"crossref","first-page":"e0244861","DOI":"10.1371\/journal.pone.0244861","article-title":"On the molecular relationship between Hounsfield unit (HU), mass density, and electron density in computed tomography (CT)","volume":"15","author":"Sudhyadhom","year":"2020","journal-title":"PLoS One."},{"key":"2026040105551070000_67.4.576.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.icrp.2007.10.003]"},{"key":"2026040105551070000_67.4.576.23","unstructured":"Recommendations of the International Commission on Radiological Protection. ICRP publication 26. https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/ANIB_1_3. Accessed January 13, 2026."},{"key":"2026040105551070000_67.4.576.24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1524\/ract.1993.60.1.1","article-title":"The chemical fate of 212Bi-DOTA formed by - decay of 212Pb(DOTA)2-","volume":"60","author":"Mirzadeh","year":"1993","journal-title":"Radiochim Acta."},{"key":"2026040105551070000_67.4.576.25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/pharmaceutics15020414","article-title":"Preclinical evaluation of a lead specific chelator (PSC) conjugated to radiopeptides for 203Pb and 212Pb-based theranostics","volume":"15","author":"Li","year":"2023","journal-title":"Pharmaceutics."},{"key":"2026040105551070000_67.4.576.26","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.3390\/molecules27185831","article-title":"Dosimetry of [212Pb]VMT01, a MC1R-targeted alpha therapeutic compound, and effect of free 208Tl on tissue absorbed doses","volume":"27","author":"Orcutt","year":"2022","journal-title":"Molecules."},{"key":"2026040105551070000_67.4.576.27","doi-asserted-by":"crossref","unstructured":"Graves S Li M Lee D Schultz MK . On the use of 203Pb imaging to inform 212Pb dosimetry for 203\/212Pb image-guided alpha-particle therapy for cancer. In: Prasad V , ed. Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum. Springer; 2024:277287.","DOI":"10.1007\/978-3-031-33533-4_28"},{"key":"2026040105551070000_67.4.576.28","doi-asserted-by":"publisher","DOI":"10.1177\/0146645317717209"},{"key":"2026040105551070000_67.4.576.29","unstructured":"Bevington PR Robinson DK . Data Reduction and Error Analysis for the Physical Sciences. McGraw-Hill; 1992:146."},{"key":"2026040105551070000_67.4.576.30","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/mp.12886","article-title":"Technical note: single time point dose estimate for exponential clearance","volume":"45","author":"Madsen","year":"2018","journal-title":"Med Phys."},{"key":"2026040105551070000_67.4.576.31","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262650"},{"key":"2026040105551070000_67.4.576.32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40658-022-00462-2","article-title":"Patient-specific dosimetry adapted to variable number of SPECT\/CT time-points per cycle for 177Lu-DOTATATE therapy","volume":"9","author":"Vergnaud","year":"2022","journal-title":"EJNMMI Phys."},{"key":"2026040105551070000_67.4.576.33","doi-asserted-by":"crossref","unstructured":"Taylor BN Kuyatt CE . Guidelines for Evaluating and Expressing the Uncertainty of NIST Measurement Results. NIST Technical Note 1297. 1994 Edition. https:\/\/emtoolbox.nist.gov\/publications\/nisttechnicalnote1297s.pdf. Accessed January 13, 2026.","DOI":"10.6028\/NIST.TN.1297"},{"key":"2026040105551070000_67.4.576.34","unstructured":"Iso I Oiml B . Guide to the Expression of Uncertainty in Measurement. Aenor; 1993:59."},{"key":"2026040105551070000_67.4.576.35","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/17474124.2019.1685381","article-title":"177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors","volume":"13","author":"Das","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"2026040105551070000_67.4.576.36","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.058651"},{"key":"2026040105551070000_67.4.576.37","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0778-1"},{"key":"2026040105551070000_67.4.576.38","unstructured":"B M-M Chist V Dulieu C . Table of Radionuclides (Vol. 2-A = 151 to 242). Bureau International des Poids et Mesures; 2004."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.270083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:18:34Z","timestamp":1785269914000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.270083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.2967\/jnumed.125.270083"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.270083","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}